Search Results

Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.

On June 1, 2021, the Governor of Louisiana signed legislation that banned “white bagging” in the state, ensuring that health insurers cannot refuse to pay for approved physician-administered drugs and related services to covered patients. It is the first such law in the United States.

In March, the Wisconsin legislature passed the 2021 Wisconsin Act 9 with overwhelming bipartisan support. Enactment of this PBM reform legislation establishes, for the first time, PBM oversight in Wisconsin.

No one disputes the need to rein in U.S. healthcare costs. However, for patients with cancer and the providers who care for them, the increasing burden of prior authorizations, step therapy requirements, and the lack of transparency regarding certain PBM business practices add on costs. Find out what advocates in Tennessee are doing to enact reform at the state level.